LEADER 03013nam 22004575 450 001 9910369947603321 005 20200702033249.0 010 $a3-030-31471-5 024 7 $a10.1007/978-3-030-31471-2 035 $a(CKB)5280000000190187 035 $a(MiAaPQ)EBC5997265 035 $a(DE-He213)978-3-030-31471-2 035 $a(PPN)242820379 035 $a(EXLCZ)995280000000190187 100 $a20191217d2020 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aOncology in the Precision Medicine Era $eValue-Based Medicine /$fedited by Ravi Salgia 205 $a1st ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (xiii, 351 pages) $cillustrations 311 $a3-030-31470-7 327 $aHealthcare Perspective -- Lung Cancer -- Esophageal and Gastric Cancer- Sarcomas -- Multiple Myeloma -- Pancreatic Cancer -- Colon Cancer -- Renal Cell Carcinoma -- Prostate Cancer -- Bladder Cancer -- Ovarian Cancer -- Genomic Cancer Risk Assessment -- Triple Negative Breast Cancer -- Melanoma -- Digital Patient Engagement and Social Media -- Hepatocellular Carcinoma -- Head and Neck Cancer -- Primary Central Nervous System Tumors -- Lymphoma. 330 $aThis volume comprehensively reviews oncology in the precision medicine era of personalized care, latest developments in the field, and indications and clinical trials for the treatment of cancer with targeted therapies, immunotherapy, and epigenetic modulators. It thoroughly addresses concerns of various types of cancers including cancers of the head and neck, lung, colon, esophagus, bladder, pancreas, and breast; melanoma; multiple myeloma; hepatocellular carcinoma; renal cell carcinoma; and sarcomas. It is organized and written in a format that is easy to follow for both clinicians and non-clinical scientists interested in personalized medicine. Chapters cover the identification of the clinical problem and summary of recent findings, tumor biology and heterogeneity, genomics, examples of simple and complex cases, biological pathways, future clinical trials, and financial considerations. Oncology in the Precision Medicine Era: Value-Based Medicine will serve as a useful resource for medical oncologists and healthcare providers tailoring medicine to the needs of the individual patient, from prevention and diagnosis to treatment and follow up. 606 $aOncology 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 615 0$aOncology. 615 14$aOncology. 676 $a616.99406 676 $a616.99406 702 $aSalgia$b Ravi$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910369947603321 996 $aOncology in the Precision Medicine Era$92287887 997 $aUNINA